Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | WTX-330 |
Trade Name | |
Synonyms | WTX 330|WTX330 |
Drug Descriptions |
WTX-330 comprises IL-12 linked to an antibody blockade domain and a half-life extension domain by linkers that can be cleaved by proteases in the tumor microenvironment, which potentially enhances antitumor immune response and reduces tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2055). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
WTX-330 | WTX-330 | 0 | 1 |